Navigation Links
Outsourcing of IT Requirements by Healthcare Organisations Promotes All-Round Benefits, Says Frost & Sullivan
Date:8/5/2009

ormation systems, the degree to which its current processes are automated, and the integrity of its current infrastructure. Vendors can respond accordingly by offering competitive prices and flexible payment options.

"The ability of vendors to reduce costs for customers and subsequently make IT outsourcing solutions more attractive is one of the most important factors in this market," says Nikolopoulos. "A 'pay as you use' service, for example, can result in many smaller hospitals jumping on board, thereby increasing the installed base of loyal customers and setting the base for larger business opportunities in the future."

European Outsourcing Market for Healthcare IT is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: Competitive Benchmarking of Key Participants in the European Healthcare IT Industry, The Healthcare IT Professional Services Market in Europe and, Mobile Healthcare Technologies in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CareTech Extends IT Outsourcing Contract with The Christ Hospital
2. Millstone Medical Outsourcing Expands Capacity, Enhances Loaner Kit Processing Services with New Equipment
3. IBM and Ferrosan Sign Seven-Year Outsourcing Contract
4. CSC Receives SAP Pinnacle Award for Global IT Outsourcing
5. Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services
6. Millstone Medical Outsourcing Expands Memphis Facility to Accommodate Growth
7. Mobile Emergency Group Implements DST Health Solutions Revenue Cycle Management Outsourcing Services
8. Apollo Health Street Has Earned the Number One Spot in the BPO Healthcare Providers Segment in the Prestigious Black Book of Outsourcing Customer Satisfaction Survey, 2008
9. Millstone Medical Outsourcing Opens New Facility to Provide Additional Capacity for Advanced Inspection, Clean Room Operations
10. CSC Signs Five-Year Outsourcing Extension With Aspen Valley Hospital
11. CPEhr Releases New White Paper Highlighting Value of Human Resources Outsourcing In A Recession

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ness could lead mothers to overlook needed care, s...hDay News) -- A mother,s depression can worsen her... Their six-month study of 262 black mothers and th... more depressive symptoms had more frequent asthma...pressive symptoms had less frequent asthma symptom...
(Date:11/25/2009)...v.25/PRNewswire/-- MISSIONSkincare ®isproudto...ude.AspartofGNC,sannualSt.Jude ThanksandGiving cam...e,s new SUPER-C(TM)LipBalm willbedonatedtoSt.Jud...ea$1,$5or$10donationatcheckoutatoneoftheir5,000+re...millionforSt.Judeduringtheir2009 ThanksandGiving c...
(Date:11/25/2009)... -- A cancer vaccine carried into the body on a ca...e first to successfully eliminate tumors in mammal...ence Translational Medicine . , The new approach...arvard University, uses plastic disks impregnated ...he skin to reprogram the mammalian immune system t...
(Date:11/25/2009)...ced under the skin kill tumor cells, study finds ,...- A cancer vaccine delivered in a fingernail-size ...study reports. , The method uses polymer disks,... tumor-specific antigens and implanted under the s...s. The Harvard University scientists who developed...
(Date:11/25/2009)... Initiative expands to include cost-effecti...achers, and healthcare professionals in developing...(PRWEB) November 25, 2009 -- Elluminate, Inc. , t...ing solutions that support 21st century teaching,... its Fire and Ice initiative was awarded iNACOL...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
...to a New Jersey Hospital, RIDGEWOOD, N.J., June 1...ader and well-known community philanthropist,has p...Valley Hospital in,Ridgewood, NJ. The gift of $30 ...his gift to Valley because I want my giving to do ...
...d nonprofit Los Angeles,Jewish Home announced toda...ess program designed to address one of the major h...funded by the Jewish Community Foundation,the larg...care,the Home provides to all its residents and in...
...therapy in the treatment of bowel cancer can enhan...onal therapies. The technique has managed to apply...l volume and risk areas, while minimising irradiat...conventional ones. In this way the treatment time ...
...d deaths, the gap between black and white American...archers at the Johns Hopkins Bloomberg School of P...d 2005 injury-related deaths among blacks ages 15 ..."Between the years of 1999 and 2005 the injury mor...
... Event, held recently in Cancun, Mexico, attracte...nada - who are, looking to retire overseas. Reason...ess to quality health care and a lower cost of liv...on,t make mistakes. That was the premise of the,In...
...ical Enterprises,Inc.), a privately held medical d...ry implant technology, today announced the launch ...nt designed for internal fixation of,bone., The B...s shape when heated above body temperature to prov...
Other Medicine News:Health News:The Valley Hospital in Ridgewood, NJ, Announces Historic $30 Million Gift 2Health News:Los Angeles Jewish Home Institutes New Fall Prevention Program With Jewish Community Foundation Grant 2Health News:Los Angeles Jewish Home Institutes New Fall Prevention Program With Jewish Community Foundation Grant 3Health News:Modulated radiotherapy can cut treatment time for cancer of the rectum without increasing toxicity 2Health News:Racial disparities reduced in injury related mortality 2Health News:International Living Ultimate Event Attracts Nearly 300 Attendees Who Explore the Growing Trend of Retiring Overseas 2Health News:International Living Ultimate Event Attracts Nearly 300 Attendees Who Explore the Growing Trend of Retiring Overseas 3Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant 2
(Date:11/25/2009)....,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.tod...iefexecutiveofficer,willpresentatthePiperJaffray21...1,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fer...gantibioticclinicalprogramsforthetreatmentofdrug-r...Pharmaceuticals ,, Foundedin2006,CempraPharmac...
(Date:11/25/2009)...alif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,anno...y,sPROTECT-1(theProspectiveRandomizedOralTherapyEv...X282-B)inpatientswithmoderate-to-severeCrohn,sdise...yandtolerabilityprofile.Thestudydemonstratedeviden...yasdefinedasa70-pointdecreaseintheCrohn,sDiseaseAc...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRM...nofReorganizationandDisclosureStatementtoday,Novem...eDistrictofDelaware.Ahearingtoconsiderapprovalofth...r8,2009,withthehearingontheconfirmationofthePlansc...ompanytopayallclaimsinfull.ThePlanisexpected,ifapp...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 1Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 2Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 1Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 2Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 4Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 5Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 6Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 7Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 8Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 1Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 2Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 3
... increase in advanced non-small cell, lung cancer ...clitaxel and cisplat...include reductions in chemotherapy-indu...OKYO, March 18 BioNumerik,Pharmaceuticals, Inc. (...ASKA") today announced the results of a Phase III ...
... 2b in Second Quarter of 2008 - - Conferen... DIEGO, March 17 Ardea Biosciences, Inc.,(Nasdaq:...lts from its,ongoing Phase 2a proof-of-concept stu...oside reverse transcriptase inhibitor (NNRTI), in,... Preliminary results from the first two of three ...
Other Medicine Technology:BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 2BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 3BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 4BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 5Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4
UPJ Occlusion Balloon Catheter
Omega NV Balloon Ureteral Dilator Sets
AquaGuide Ureteral Access Sheath
Flexible Ureteroscopy Sheath Set
Medicine Products: